SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001564590-22-016823
Filing Date
2022-04-29
Accepted
2022-04-29 16:26:24
Documents
15
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A txmd-10ka_20211231.htm   iXBRL 10-K/A 1304777
2 EX-31.1 txmd-ex311_7.htm EX-31.1 9182
3 EX-31.2 txmd-ex312_10.htm EX-31.2 9716
4 GRAPHIC g5dagmtxvkvn000001.jpg GRAPHIC 4411
  Complete submission text file 0001564590-22-016823.txt   1624209

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA txmd-20211231.xsd EX-101.SCH 5717
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE txmd-20211231_lab.xml EX-101.LAB 31155
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE txmd-20211231_pre.xml EX-101.PRE 18754
9 EXTRACTED XBRL INSTANCE DOCUMENT txmd-10ka_20211231_htm.xml XML 9833
Mailing Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431
Business Address 951 YAMATO ROAD, SUITE 220 BOCA RATON FL 33431 561-961-1900
TherapeuticsMD, Inc. (Filer) CIK: 0000025743 (see all company filings)

IRS No.: 870233535 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-00100 | Film No.: 22876008
SIC: 2834 Pharmaceutical Preparations